Capnography Devices Market Summary

The global capnography devices market size was valued at USD 0.67 billion in 2023 and is projected to reach USD 1.31 billion by 2030, growing at a CAGR of 10.0% from 2024 to 2030. Expected technological advancements, the rising prevalence of respiratory disorders, and increased support from government initiatives are key factors contributing to the robust expansion of the market during the forecast period. These combined drivers are significantly improving the adoption rate of capnography across hospitals, clinics, and emergency care facilities worldwide.

Attributed to its superior reliability and clinical effectiveness, the growing use of capnography for managing various respiratory conditions is anticipated to strengthen the diagnostic and monitoring capabilities of healthcare providers. This technology plays an essential role in assessing ventilation status, detecting respiratory distress early, and supporting critical care interventions. For instance, in 2022, 4.6% of adults had been diagnosed with COPD, emphysema, or chronic bronchitis at some point. Office-based physician visits where COPD appeared in the medical record accounted for 4.2%. Additionally, an estimated 791,000 emergency department visits were recorded where COPD was the primary reason for seeking care, highlighting the increasing healthcare burden of respiratory diseases.

Key Market Trends & Insights

• North America capnography devices market held the largest revenue share globally of more than 42.8% in 2023, supported by advanced healthcare systems, strong clinical awareness, and high adoption of respiratory monitoring technologies.
• Asia Pacific capnography devices market is anticipated to witness significant growth due to expanding healthcare infrastructure, improving access to emergency care, and rising awareness regarding the importance of effective respiratory monitoring.
• Based on application, the emergency medicine segment accounted for the largest market revenue share of 24.0% in 2023, owing to the essential role of capnography in rapid patient assessment and critical decision-making.
• In terms of type, the hand-held segment accounted for the largest market revenue share of 60.6% in 2023, driven by its portability, ease of use, and widespread utilization in both hospital and pre-hospital settings.
• Based on end use, the hospitals segment accounted for the largest market revenue share of 57.7% in 2023, reflecting the high demand for capnography devices in surgical procedures, intensive care, and emergency departments.

Order a free sample PDF of the Capnography Devices Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2023 Market Size: USD 0.67 Billion
• 2030 Projected Market Size: USD 1.31 Billion
• CAGR (2024-2030): 10.0%
• North America: Largest market in 2023
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights

Some of the key companies in the capnography devices market include Smiths Medical (acquired by ICU Medical Inc.), Dragerwerk AG & Co. KGaA, Baxter, Masimo, Koninklijke Philips N.V., Medtronic, Nonin, NIHON KOHDEN CORPORATION, BD, Diamedica (UK) Limited, and EDAN Instruments, Inc. Organizations are focusing on increasing customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions, and partnerships with other major companies. 

• Smiths Medical, a division of the UK-based Smiths Group plc, is a global manufacturer of specialty medical devices serving various healthcare sectors such as critical care, anesthesia, and oncology. The company operates in over 50 countries and markets its products to more than 100 countries, catering to hospitals, clinics, and home care settings.
• Dragerwerk AG & Co. KGaA is an international company specializing in medical and safety technology, offering neonatal, intensive, prenatal, and emergency care solutions. Their product range includes monitoring, ventilation, anesthetics, warming therapy, and information management systems.

Key Players

• Smiths Medical (acquired by ICU Medical Inc.)
• Dragerwerk AG & Co. KGaA
• Baxter
• Masimo
• Koninklijke Philips N.V.
• Medtronic
• Nonin
• NIHON KOHDEN CORPORATION
• BD
• Diamedica (UK) Limited
• EDAN Instruments, Inc.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The capnography devices market is poised for strong growth as respiratory illnesses continue to rise and healthcare providers place greater emphasis on accurate and real-time ventilation monitoring. Technological innovation, expanding clinical applications, and supportive government initiatives will further strengthen adoption across global healthcare systems. While North America will maintain its leadership position, rapid developments in Asia Pacific are expected to accelerate regional demand. As hospitals and emergency care settings increasingly rely on capnography to improve patient outcomes, manufacturers focusing on user-friendly designs, higher accuracy, and enhanced portability will gain a competitive advantage in this expanding market.